Knee Arthroplasty
Conditions
Brief summary
This post-market clinical follow-up study intends to investigate the survival rate at 5 years of the e.motion® PS Pro System.
Interventions
DEVICETotal Knee prothesis e motion PS Pro
Sponsors
BBraun Medical SAS
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient having signed informed consent * Patients over 18 for which a Total Knee Prosthesis with e.motion® PS Pro was decided * Patients willing to participate in a 5 years follow-up
Exclusion criteria
* Active or suspected infection * Tumor on the concerned knee * Patient vulnerable and under legal protection
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Survival rate at 5 years of the e motion PS Pro | the survival rate will be evaluated 6-12 weeks; 1; 2; 3; 4 and 5 years after the knee arthroplasty | The endpoint is the revision of at least one of the prosthesis components. If a patient withdraws from the study for any reason, counts as the end date for the survival of the implant of the last day on which the implants were well known even in place. |
Countries
France
Contacts
Primary ContactFrançois Boillot
Backup ContactBoubker Zniber
Outcome results
None listed